Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis
Clinical trial NCT04541680 · UNKNOWN
Trial details
- NCT number
- NCT04541680
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-29
- Primary completion
- 2023-10-11
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.